Android app on Google Play

Amgen (AMGN) Copletes Mustafa Nevzat Pharma Acquisition

June 12, 2012 4:10 PM EDT Send to a Friend
Amgen (Nasdaq: AMGN) announced the completion of the acquisition of more than 99 percent of the shares of Mustafa Nevzat Pharmaceuticals, a privately held Turkish company. The all-cash transaction significantly expands Amgen's presence in Turkey and the surrounding region, which includes several fast-growing, priority markets for Amgen. The acquisition was initially announced on April 25.




You May Also Be Interested In


Related Categories

Corporate News, Mergers and Acquisitions

Add Your Comment